title: Dermal interleukin-1 expression and effective and long-lasting therapy with interleukin-1 receptor antagonist anakinra in Schnitzler syndrome.
authors.affiliation: Department of Dermatology, Eberhard Karls University, DE-72076 Tübingen, Germany.
authors.forename: Thomas
authors.initials: T
authors.lastname: Volz
authors.forename: Florian
authors.initials: F
authors.lastname: Wölbing
authors.forename: Jörg
authors.initials: J
authors.lastname: Fischer
authors.forename: Martin
authors.initials: M
authors.lastname: Braun
authors.forename: Iryna
authors.initials: I
authors.lastname: Maggoschitz
authors.forename: Martin
authors.initials: M
authors.lastname: Schaller
authors.forename: Mark
authors.initials: M
authors.lastname: Berneburg
authors.forename: Tilo
authors.initials: T
authors.lastname: Biedermann
mesh_terms: D001706:Biopsy; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D053583:Interleukin-1beta / Q000032:analysis*; D008875:Middle Aged; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors*; D012074:Remission Induction; D019873:Schnitzler Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D012867:Skin / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D053590:Interleukin 1 Receptor Antagonist Protein; D053583:Interleukin-1beta; D017472:Receptors, Interleukin-1